Egyptian Exchange: Macro Group resumes IPO plan
Macro Group Pharmaceuticals will continue the procedures of its listing on the Egyptian Exchange (EGX) through an initial public offering (IPO) by the end of 2021 or early 2022, the company’s chairman Ahmed El Nayeb told Al Borsa Newspaper.